0001140361-12-025631.txt : 20120516 0001140361-12-025631.hdr.sgml : 20120516 20120516092913 ACCESSION NUMBER: 0001140361-12-025631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120516 FILED AS OF DATE: 20120516 DATE AS OF CHANGE: 20120516 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLAXOSMITHKLINE PLC CENTRAL INDEX KEY: 0001131399 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 12847399 BUSINESS ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS BUSINESS PHONE: 011442080475000 MAIL ADDRESS: STREET 1: 980 GREAT WEST ROAD CITY: BRENTFORD MIDDLESEX STATE: X0 ZIP: TW8 9GS 4 1 doc1.xml FORM 4 X0305 4 2012-05-16 0 0001080014 THERAVANCE INC THRX 0001131399 GLAXOSMITHKLINE PLC 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS UNITED KINGDOM 0 0 1 0 Common Stock 2012-05-16 4 P 0 10000000 21.2887 A 25814421 I By Corporation Common stock purchased pursuant to the Common Stock Purchase Agreement by and among Theravance, Inc. (the "Issuer"), GlaxoSmithKline LLC and Glaxo Group Limited ("GGL"), dated as of April 2, 2012, pursuant to which the Issuer agreed to issue and sell and GGL agreed to purchase 10,000,000 shares of Common Stock. Shares of Common Stock are held of record by GGL. /s/ Victoria A. Whyte, Company Secretary 2012-05-16